GeneCast Company
%20.jpg)
GeneCast provides cancer screening, monitoring, precision care and accompanying diagnosis through source technology that amplifies only mutated genes.
Funding Status:
Early Stage Venture
Headquarters:
South Korea
Founded Date:
42675
Last Funding Type:
Series A
Total Funding:
$93.5M
Estimated Revenue:
$1M to $10M
Industry:
Health Care
Investors Number:
8
Technology:
preventive
Last Funding Date:
43188